{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/64fa76e3ec7d250011625620?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Friday, September 8, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1694136003734-81c8608979792853c70e46bde7df16d9.jpeg?height=200","description":"<p>A new study finds that Medicare Advantage plans were overpaid by billions of dollars each year from 2017 to 2020. The cost of employer-sponsored health insurance is expected to surge next year. And, researchers are investigating whether weight loss drugs Ozempic and Wegovy could be used to treat alcohol addiction and dementia.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}